IRIS
LEONI, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.207
EU - Europa 6.699
AS - Asia 4.346
SA - Sud America 1.337
AF - Africa 330
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 8
Totale 23.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.071
SG - Singapore 1.503
UA - Ucraina 1.401
BR - Brasile 1.147
SE - Svezia 855
CN - Cina 797
IT - Italia 770
DE - Germania 752
RU - Federazione Russa 716
IE - Irlanda 707
TR - Turchia 666
DK - Danimarca 541
HK - Hong Kong 452
FI - Finlandia 353
VN - Vietnam 344
KR - Corea 291
GB - Regno Unito 252
FR - Francia 184
CI - Costa d'Avorio 155
MA - Marocco 112
IN - India 77
AR - Argentina 72
CA - Canada 67
MX - Messico 51
EC - Ecuador 39
ID - Indonesia 37
BD - Bangladesh 35
JP - Giappone 35
PL - Polonia 35
ZA - Sudafrica 31
BE - Belgio 27
EU - Europa 25
IQ - Iraq 25
PY - Paraguay 22
AT - Austria 20
ES - Italia 20
CO - Colombia 18
NL - Olanda 16
UZ - Uzbekistan 16
VE - Venezuela 14
PK - Pakistan 12
CZ - Repubblica Ceca 10
RO - Romania 10
CL - Cile 8
PE - Perù 8
JO - Giordania 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
KE - Kenya 6
LT - Lituania 6
OM - Oman 6
TN - Tunisia 6
UY - Uruguay 6
BG - Bulgaria 5
DZ - Algeria 5
NP - Nepal 5
EG - Egitto 4
GR - Grecia 4
AZ - Azerbaigian 3
BO - Bolivia 3
BZ - Belize 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CG - Congo 2
CR - Costa Rica 2
JM - Giamaica 2
KW - Kuwait 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 23.948
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.424
Chandler 1.049
Ashburn 917
Singapore 839
Fairfield 779
Boardman 704
Dublin 704
Dallas 692
Wilmington 474
Hong Kong 450
Woodbridge 351
New York 341
Houston 305
San Mateo 291
Seattle 291
Lawrence 286
Princeton 286
Des Moines 233
Cambridge 212
Beijing 195
Ann Arbor 189
Los Angeles 175
Hefei 171
Centro 166
Moscow 158
Abidjan 155
Ho Chi Minh City 126
The Dalles 126
San Diego 116
Munich 93
Redmond 93
Buffalo 92
São Paulo 91
Porto 79
Hanoi 74
Turin 53
Shanghai 42
Milan 40
London 39
Helsinki 34
Turku 34
Guangzhou 33
Rio de Janeiro 32
Chicago 30
Pune 30
Tokyo 29
Norwalk 27
Pianella 27
Warsaw 27
Curitiba 26
Stockholm 26
Brussels 25
Brooklyn 24
Marche 23
Phoenix 23
Porto Alegre 21
Montreal 20
Santa Clara 20
Belo Horizonte 19
Izmir 19
Mexico City 19
Poplar 19
Denver 17
Manchester 17
Orem 17
Auburn Hills 16
Boston 16
Nuremberg 16
Ancona 15
Civitanova Marche 15
Da Nang 15
Johannesburg 15
Rome 15
Toronto 15
Washington 15
Wuhan 15
Brasília 14
Tashkent 14
Atlanta 13
Frankfurt am Main 13
Guarulhos 13
Haiphong 13
Hải Dương 13
San Francisco 13
Campinas 12
Chennai 11
Columbus 11
Council Bluffs 11
Guayaquil 11
Baghdad 10
Biên Hòa 10
Jinhua 10
Olomouc 10
Prescot 10
Querétaro 10
Recife 10
Ribeirão Preto 10
Secaucus 10
Venice 10
Vienna 10
Totale 13.979
Salva come PNG Salva come JPEG
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 232
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 180
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 169
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 158
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 157
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 150
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 149
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 146
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 140
Glial-like differentiation potential of human mature adipocytes 140
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 138
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 135
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 135
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 134
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 133
Primary B-cell lymphoblastic lymphoma of the testis 133
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 133
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 131
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 130
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 129
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 126
Meningioma-like cerebral relapse of Hodgkin's disease. 125
[Hodgkin's lymphoma and secondary leukemias]. 125
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 124
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 122
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 122
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 122
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 122
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 122
Biosafety evidence for human dedifferentiated adipocytes 122
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 121
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 120
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 120
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 119
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 118
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 118
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 117
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 116
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 116
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 116
Plasticity of human dedifferentiated adipocytes toward endothelial cells 116
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 115
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 115
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 115
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 114
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 113
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 113
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 113
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 113
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 113
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 112
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 111
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 110
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 110
Bone marrow adipocytes support haematopoietic stem cell survival 110
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 110
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 109
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 109
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 108
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 108
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 107
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 107
Molecular and functional characterization of human bone marrow adipocytes 107
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 106
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 106
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 106
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 104
[Beta 2-microglobulin in lymphoproliferative disorders]. 104
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 103
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 102
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 102
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 101
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 101
[Peripheral neuropathy associated with Castleman's lymphoma]. 100
[Hairy cell leukemia: therapy with lithium carbonate]. 100
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 100
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 99
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 98
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 98
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 98
Identification of different adypocytes populations within human marrow microenvironment 98
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 97
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 97
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 97
The value of PCR in the diagnosis and monitoring of early stage of mycosis fungoids treated with Interferon plus PUVA 97
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 97
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 97
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 96
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 96
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 96
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 95
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 95
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 95
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 93
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 93
Bone marrow extracellular large geometric crystals in IgG/λ MGUS 93
TIME TO NEXT TREATMENT ANALYSIS FOR EARLY AND ADVANCED STAGES OF MYCOSIS FUNGOIDES/SEZARY SYNDROME TREATED WITH BEXAROTENE AND PUVA IN COMBINATION 93
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 93
High remission rate in T-Cell prolymphocytic leukemia with Campath-1H 92
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 92
Totale 11.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.939 0 0 0 0 0 193 358 162 426 266 388 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.923 429 424 172 48 169 78 486 113 868 285 353 498
2025/20264.533 707 793 707 1.237 898 191 0 0 0 0 0 0
Totale 24.314